Observational studyClinical and translational science2021

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.

Theresa H Wirtz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.